BioCentury
ARTICLE | Clinical News

Cima, Zeneca Group plc regulatory update

February 22, 1999 8:00 AM UTC

Zeneca filed a European MAA for its Zomig zolmitriptan to treat migraine. Zomig was developed using CIMA’s OraSolv fast-dissolve tablet formulation. ...